"Visit the UCLA Health website for coronavirus updates."

During the past decade, UCLA Cancer Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 7 clinical trials were completed, i.e. on average, 700% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCLA Cancer Center" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "UCLA Cancer Center" are "Breast Neoplasms" (1 trials), "Carcinoma Non-small Cell Lung Cancer Stage IIIA" (1 trials), "Carcinoma Non-small Cell Lung Cancer Stage IIIB" (1 trials), "Carcinoma Non-small Cell Lung Cancer Stage IV" (1 trials) and "Low-grade Serous Fallopian Tube Cancer" (1 trials). Many other conditions were trialed in "UCLA Cancer Center" in a lesser frequency.

Most popular intervention types in "UCLA Cancer Center" are "Drug" (7 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Active Comparator (erlotinib)" (1 trials), "Alclometasone cream" (1 trials), "Bevacizumab" (1 trials) and "Dacomitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCLA Cancer Center" are 5 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "UCLA Cancer Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in UCLA Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UCLA Cancer Center, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".